Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Intangibles (2018 - 2020)

Vanda Pharmaceuticals' Change in Intangibles history spans 3 years, with the latest figure at $37.5 million for Q1 2020.

  • For Q1 2020, Change in Intangibles changed N/A year-over-year to $37.5 million; the TTM value through Mar 2020 reached $37.5 million, changed N/A, while the annual FY2018 figure was $25.0 million, N/A changed from the prior year.
  • Change in Intangibles for Q1 2020 was $37.5 million at Vanda Pharmaceuticals, up from $25.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $37.5 million in Q1 2020 and bottomed at $25.0 million in Q2 2018.